RCBTB2 and cancer: The mechanisms include mutation of protein-targeting signals, dysregulation of transporter machinery, aberrant endocytosis and vesicular trafficking, dysregulation of signal transduction and protein post-translational modification, alteration of protein-protein interactions, and cross-regulation of cancer-related proteins.24Until now, the knowledge regarding aberration of CHC1L in OSCC is extremely limited.